Anti-Viral Drug for Covid-19 Current Affairs, GK & News

Molnupiravir: New drug to treat COVID-19

On October 1, 2021, Pharmaceutical company “Merck and Ridgeback Biotherapeutics” announced the early results of Phase-3 trials of its anti-viral drug called molnupiravir. As per the results, Molnupiravir has reduced the chances of hospitalisation by half among COVID-19 patients with mild or moderate symptoms. Highlights Placebo trials comprised of testing a drug on thousands of ..

Month: 

Category: 

Topics: